Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-24
2005-05-24
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S342000, C514S343000, C546S280400, C546S279100, C546S278400, C546S281100
Reexamination Certificate
active
06897226
ABSTRACT:
Compounds of the invention are amine oxide prodrugs showing activity on the NK1 receptor.
REFERENCES:
patent: 5691336 (1997-11-01), Dorn et al.
patent: 5932587 (1999-08-01), Schmeck et al.
patent: 5972938 (1999-10-01), Rupniak et al.
patent: 6297375 (2001-10-01), Bos et al.
patent: 6479483 (2002-11-01), Bos et al.
patent: 6593472 (2003-07-01), Hoffmann et al.
patent: 20030083345 (2003-05-01), Hoffman et al.
patent: WO 9516679 (1995-06-01), None
patent: WO9518124 (1995-07-01), None
patent: WO 9523798 (1995-09-01), None
Neurosci. Res., vol. 7, pp. 187-214, 1996.*
Can. J. Phys., 75, pp. 612-621, vol. 75.*
Science, vol. 281, pp. 1640-1645, 1998.*
Eur. J. Pharmacol., 383, (3), 297-303 (1999).*
J. Auton. Pharmacol. 13, 23-93, 1993.*
Ca 122:281401, “Aliphatic amine N-oxides of DNA Binding agents as bioreductive drugs”, Patterson et. al.*
Harrison et al., J. Med. CHem., 44: 4296-4299 (2001).
Ladabaum et al., Dig. Dis., 17: 125-132 (1999).
Massi et al., Peptides, 21: 1597-1609 (2000).
Vassout et al., Regulatory Peptides, 96: 7-16 (2000).
Rupniak et al., Neuropharmacology, 39: 1413-1421 (2000).
Renzi et al., Am. J. of Path., 157: 1511-1522 (2000).
Moriarity et al., British Journal of Pharmacology, 133: 1346-1354 (2001).
Phebus et al., Life Sciences, 60(18): 1553-1561 (1997).
Hoffmann Torsten
Poli Sonia Maria
Schnider Patrick
Sleight Andrew
Davis Zinna Northington
Hoffmann-La Roche Inc.
Johnston George W.
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
LandOfFree
NK-1 receptor active amine oxide prodrugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NK-1 receptor active amine oxide prodrugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NK-1 receptor active amine oxide prodrugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3456687